Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Biogen Pharmachem Industries LtdIndustry : Finance & Investments
BSE Code:531752NSE Symbol: Not ListedP/E(TTM):17.33
ISIN Demat:INE703D01023Div & Yield %:0EPS(TTM):0.03
Book Value(Rs):1.0977251Market Cap ( Cr.):46.94Face Value(Rs):1
    Change Company 
Date Headline
24-Feb-26 Biogen Pharmachem Industries to consider Bonus Issue
24-Feb-26 Biogen to consider proposal of bonus issue on 23 Mar
11-Feb-26 Biogen Pharmachem Industries reports standalone net profit of Rs0.46 crore in the December 2025 quarter
20-Jan-26 Biogen Pharmachem Industries to convene board meeting
07-Nov-25 Biogen Pharmachem Industries reports standalone net loss of Rs0.49 crore in the September 2025 quarter
31-Oct-25 Biogen Pharmachem Industries to discuss results
26-Aug-25 Biogen Pharmachem Industries to convene AGM
25-Aug-25 Biogen Pharmachem Industries Ltd - Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities ..
25-Aug-25 Biogen Pharmachem Industries Ltd - Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange B..
25-Aug-25 Biogen Pharmachem Industries Ltd - Reg. 34 (1) Annual Report.
<< < 1 2 > >>